Angiotensin II receptor blockers for the treatment of portal hypertension in patients with liver cirrhosis: a systematic review and meta-analysis of randomized controlled trials
ConclusionsARBs did not reduce portal pressure in patients with cirrhosis; moreover, the risk of symptomatic hypotension may increase.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research
More News: Biomedical Science | Cirrhosis | Databases & Libraries | General Medicine | Hypertension | Inderal | Ireland Health | Liver | Science | Study | Urology & Nephrology